Strońska-Pluta, A.; Suchanecka, A.; Chmielowiec, K.; Chmielowiec, J.; Boroń, A.; Masiak, J.; Sipak-Szmigiel, O.; Recław, R.; Grzywacz, A.
The Relationship between the Brain-Derived Neurotrophic Factor Gene Polymorphism (Val66Met) and Substance Use Disorder and Relapse. Int. J. Mol. Sci. 2024, 25, 788.
https://doi.org/10.3390/ijms25020788
AMA Style
Strońska-Pluta A, Suchanecka A, Chmielowiec K, Chmielowiec J, Boroń A, Masiak J, Sipak-Szmigiel O, Recław R, Grzywacz A.
The Relationship between the Brain-Derived Neurotrophic Factor Gene Polymorphism (Val66Met) and Substance Use Disorder and Relapse. International Journal of Molecular Sciences. 2024; 25(2):788.
https://doi.org/10.3390/ijms25020788
Chicago/Turabian Style
Strońska-Pluta, Aleksandra, Aleksandra Suchanecka, Krzysztof Chmielowiec, Jolanta Chmielowiec, Agnieszka Boroń, Jolanta Masiak, Olimpia Sipak-Szmigiel, Remigiusz Recław, and Anna Grzywacz.
2024. "The Relationship between the Brain-Derived Neurotrophic Factor Gene Polymorphism (Val66Met) and Substance Use Disorder and Relapse" International Journal of Molecular Sciences 25, no. 2: 788.
https://doi.org/10.3390/ijms25020788
APA Style
Strońska-Pluta, A., Suchanecka, A., Chmielowiec, K., Chmielowiec, J., Boroń, A., Masiak, J., Sipak-Szmigiel, O., Recław, R., & Grzywacz, A.
(2024). The Relationship between the Brain-Derived Neurotrophic Factor Gene Polymorphism (Val66Met) and Substance Use Disorder and Relapse. International Journal of Molecular Sciences, 25(2), 788.
https://doi.org/10.3390/ijms25020788
